Avoro Capital Advisors LLC Deciphera Pharmaceuticals, Inc. Transaction History

Avoro Capital Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $8.22 Million - $39.7 Million	-1,068,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $5.73 Million - $8.39 Million	175,000 Added 19.6%	1,068,000 $39.1 Million
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $16.4 Million - $23.1 Million	-407,000 Reduced 31.31%	893,000 $40 Million
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $26.9 Million - $34.4 Million	-520,000 Reduced 28.57%	1,300,000 $74.2 Million
Q3 2020 Nov 16, 2020	SELL	$43.8 - $58.16 $1.75 Million - $2.33 Million	-40,000 Reduced 2.15%	1,820,000 $93.4 Million
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $5.19 Million - $9.1 Million	-140,000 Reduced 7.0%	1,860,000 $111 Million
Q1 2020 May 15, 2020	BUY	$33.63 - $69.4 $50.4 Million - $104 Million	1,500,000 Added 300.0%	2,000,000 $82.3 Million
Q4 2019 Feb 14, 2020	BUY	$31.7 - $69.93 $15.9 Million - $35 Million	500,000 New	500,000 $31.1 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.